Systematic review of the depressive symptoms associated with vascular conditions

Journal of Affective Disorders

Volumn 104, Issue 1-3, 2007, Pages 25-35

  McDougall, Fiona ^a   Brayne, Carol ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Depressive disorder; Epidemiology; Vascular diseases

Indexed keywords

ANTIDEPRESSANT AGENT; NIMODIPINE;

CLINICAL TRIAL; DEPRESSION; HUMAN; MEDLINE; MOTIVATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; REVIEW; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; VASCULAR DISEASE;

CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; DEPRESSION; FATIGUE; HUMANS; MOTIVATION; PREVALENCE; PSYCHOMOTOR DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 35748979401     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.03.001     Document Type: Review

References (39)

1. Alexopoulos G.S. The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists?. Am. J. Geriatr. Psychiatry 9 1 (2001) 22-29
2. Alexopoulos G.S. Vascular disease, depression, and dementia. J. Am. Geriatr. Soc. 51 8 (2003) 1178-1180
3. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., and Charlson M. 'Vascular depression' hypothesis. Arch. Gen. Psychiatry 54 10 (1997) 915-922
4. Alexopoulos G.S., Meyers B.S., Young R.C., Kakuma T., Silbersweig D., and Charlson M. Clinically defined vascular depression. Am. J. Psychiatry 154 4 (1997) 562-565
5. Alexopoulos G.S., Kiosses D.N., Klimstra S., Kalayam B., and Bruce M.L. Clinical presentation of the "depression-executive dysfunction syndrome" of late life. Am. J. Geriatr. Psychiatry 10 1 (2002) 98-106
6. Alexopoulos G.S., Schulz S.K., and Lebowitz B.D. Late-life depression: a model for medical intervention. Biol. Psychiatry 58 4 (2005) 283-289
7. Baldwin R.C. Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. Int. J. Geriatr. Psychiatry 20 1 (2005) 1-11
8. Camus V., Kraehenbuhl H., Preisig M., Bula C.J., and Waeber G. Geriatric depression and vascular diseases: what are the links?. J. Affect. Disord. 81 1 (2004) 1-16
9. de Groot J.C., de Leeuw F.E., Oudkerk M., Hofman A., Jolles J., and Breteler M.M. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch. Gen. Psychiatry 57 11 (2000) 1071-1076
10. Dieguez S., Staub F., Bruggimann L., and Bogousslavsky J. Is poststroke depression a vascular depression?. J. Neurol. Sci. 226 1-2 (2004) 53-58
11. Figiel G.S., Krishnan K.R., Doraiswamy P.M., Rao V.P., Nemeroff C.B., and Boyko O.B. Subcortical hyperintensities on brain magnetic resonance imaging: a comparison between late age onset and early onset elderly depressed subjects. Neurobiol. Aging. 12 3 (1991) 245-247
12. Halling A., and Berglund J. Association of diagnosis of ischaemic heart disease, diabetes mellitus and heart failure with cognitive function in the elderly population. Eur. J. Gen. Pract. 12 3 (2006) 114-119
13. Heiden A., Kettenbach J., Fischer P., Schein B., Ba-Ssalamah A., Frey R., Naderi M.M., Gulesserian T., Schmid D., Trattnig S., Imhof H., and Kasper S. White matter hyperintensities and chronicity of depression. J. Psychiatr. Res. 39 3 (2005) 285-293
14. Krishnan K.R., Hays J.C., and Blazer D.G. MRI-defined vascular depression. Am. J. Psychiatry 154 4 (1997) 497-501
15. Krishnan K.R., Taylor W.D., McQuoid D.R., MacFall J.R., Payne M.E., Provenzale J.M., and Steffens D.C. Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression. Biol. Psychiatry 55 4 (2004) 390-397
16. Lampe I.K., and Heeren T.J. Is apathy in late-life depressive illness related to age-at-onset, cognitive function or vascular risk?. Int. Psychogeriatr. 16 4 (2004) 481-486
17. Lesser I.M., Boone K.B., Mehringer C.M., Wohl M.A., Miller B.L., and Berman N.G. Cognition and white matter hyperintensities in older depressed patients. Am. J. Psychiatry 153 10 (1996) 1280-1287
18. Licht-Strunk E., Bremmer M.A., van Marwijk H.W., Deeg D.J., Hoogendijk W.J., de Haan M., van Tilburg W., and Beekman A.T. Depression in older persons with versus without vascular disease in the open population: similar depressive symptom patterns, more disability. J. Affect. Disord. 83 2-3 (2004) 155-160
19. Lockwood K.A., Alexopoulos G.S., and van Gorp W.G. Executive dysfunction in geriatric depression. Am. J. Psychiatry 159 7 (2002) 1119-1126
20. Mast B.T. Cerebrovascular disease and late-life depression: a latent-variable analysis of depressive symptoms after stroke. Am. J. Geriatr. Psychiatry 12 3 (2004) 315-322
21. Mast B.T., Yochim B., MacNeill S.E., and Lichtenberg P.A. Risk factors for geriatric depression: the importance of executive functioning within the vascular depression hypothesis. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 59 12 (2004) 1290-1294
22. Miller M.D., Lenze E.J., Dew M.A., Whyte E., Weber E., Begley A.E., and Reynolds III C.F. Effect of cerebrovascular risk factors on depression treatment outcome in later life. Am. J. Geriatr. Psychiatry 10 5 (2002) 592-598
23. Naarding P., Schoevers R.A., Janzing J.G., Jonker C., Koudstaal P.J., and Beekman A.T. A study on symptom profiles of late-life depression: the influence of vascular, degenerative and inflammatory risk-indicators. J. Affect. Disord. 88 2 (2005)
24. Naarding P., Tiemeier H., Breteler M.M., Schoevers R.A., Jonker C., Koudstaal P.J., and Beekman A.T. Clinically defined vascular depression in the general population. Psychol. Med. (2006) 1-10
25. Nebes R.D., Vora I.J., Meltzer C.C., Fukui M.B., Williams R.L., Kamboh M.I., Saxton J., Houck P.R., DeKosky S.T., and Reynolds III C.F. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. Am. J. Psychiatry 158 6 (2001) 878-884
26. Newman S.C. The prevalence of depression in Alzheimer's disease and vascular dementia in a population sample. J. Affect. Disord. 52 1-3 (1999) 169-176
27. O'Brien J., Desmond P., Ames D., Schweitzer I., Harrigan S., and Tress B. A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br. J. Psychiatry 168 4 (1996) 477-485
28. O'Brien J.T., Ames D., and Schwietzer I. White matter changes in depression and alzheimer's disease: a review of magnetic resonance imaging studies. Int. J. Geriatr. Psychiatry 11 (1996) 681-694
29. O'Brien J.T., Ames D., Schweitzer I., Desmond P., Coleman P., and Tress B. Clinical, magnetic resonance imaging and endocrinological differences between delusional and non-delusional depression in the elderly. Int. J. Geriatr. Psychiatry 12 2 (1997) 211-218
30. O'Brien J., Ames D., Chiu E., Schweitzer I., Desmond P., and Tress B. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ 317 7164 (1998) 982-984
31. O'Brien J.T., Erkinjuntti T., Reisberg B., Roman G., Sawada T., Pantoni L., Bowler J.V., Ballard C., DeCarli C., Gorelick P.B., Rockwood K., Burns A., Gauthier S., and DeKosky S.T. Vascular cognitive impairment. Lancet Neurol. 2 2 (2003) 89-98
32. Polidori M.C., Marvardi M., Cherubini A., Senin U., and Mecocci P. Heart disease and vascular risk factors in the cognitively impaired elderly: implications for Alzheimer's dementia. Aging (Milano) 13 3 (2001) 231-239
33. Ramasubbu R. Relationship between depression and cerebrovascular disease: conceptual issues. J. Affect. Disord. 57 1-3 (2000) 1-11
34. Simpson S., Baldwin R.C., Jackson A., and Burns A.S. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol. Med. 28 5 (1998) 1015-1026
35. Steffens D.C. Establishing diagnostic criteria for vascular depression. J. Neurol. Sci. 226 1-2 (2004) 59-62
36. Taragano F.E., Allegri R., Vicario A., Bagnatti P., and Lyketsos C.G. A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of 'vascular depression'. Int. J. Geriatr. Psychiatry 16 3 (2001) 254-260
37. Taragano F.E., Bagnatti P., and Allegri R.F. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression". Int. Psychogeriatr. 17 3 (2005) 487-498
38. Thomas A.J., Kalaria R.N., and O'Brien J.T. Depression and vascular disease: what is the relationship?. J. Affect. Disord. 79 1-3 (2004) 81-95
39. van Straaten E.C., Fazekas F., Rostrup E., Scheltens P., Schmidt R., Pantoni L., Inzitari D., Waldemar G., Erkinjuntti T., Mantyla R., Wahlund L.O., and Barkhof F. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 37 3 (2006) 836-840